Episode 6 - Antithrombotic Strategies in Comorbid Atrial Fibrillation and CHD
Part VI of the course in pharmacotherapy in atrial fibrillation (AF) is highlighting one of the most prevalent co-morbidities to AF, namely coronary heart disease. A patient case is presented that highlights the therapeutic challenges physicians face when AF patients need a PCI, or when a NSTEMI patient suddenly develops AF. The overarching principle is to balance the ischemic risk in a given patient against the bleeding risk, an approach that deals with personalized medicine. A number of therapeutic flow-charts are provided to guide us through the recommended dual antiplatelet as well as triple antithrombotic therapy options.
Date and registration
A professor of cardiology at Oslo University Hospital in Oslo, Norway. Features in 8 videos on...Read More
A professor of cardiology at Oslo University Hospital in Oslo, Norway. Features in 8 videos on Wondr Medical. Dan Atar speaks about clinical cardiology topics, covering areas such as acute coronary syndromes, heart failure, atrial fibrillation, and secondary prevention. Further, he has a particular interest in pharmacotherapy.Show Less